SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Worek, F.
Right arrow Articles by Eyer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worek, F.
Right arrow Articles by Eyer, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Poisoning
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning

F. Worek

Institut für Pharmakologie und Toxikologie, Akademie des Sanitäts- und Gesundheitswesens der Bundeswehr, Ingolstädter Landstraße 100, D-85748 Garching

M. Bäcker

Institut für Pharmakologie und Toxikologie, Akademie des Sanitäts- und Gesundheitswesens der Bundeswehr, Ingolstädter Landstraße 100, D-85748 Garching

H. Thiermann

Institut für Pharmakologie und Toxikologie, Akademie des Sanitäts- und Gesundheitswesens der Bundeswehr, Ingolstädter Landstraße 100, D-85748 Garching

L. Szinicz

Institut für Pharmakologie und Toxikologie, Akademie des Sanitäts- und Gesundheitswesens der Bundeswehr, Ingolstädter Landstraße 100, D-85748 Garching

U. Mast

Walther-Straub-Institut für Pharmakologie und Toxikologie der Ludwig-Maximilians-Universität München, Nußbaumstraße 26, D-80336 München, Germany

R. Klimmek

Walther-Straub-Institut für Pharmakologie und Toxikologie der Ludwig-Maximilians-Universität München, Nußbaumstraße 26, D-80336 München, Germany

P. Eyer

Walther-Straub-Institut für Pharmakologie und Toxikologie der Ludwig-Maximilians-Universität München, Nußbaumstraße 26, D-80336 München, Germany

1 In vitro studies with human erythrocyte acetylcholin esterase (AChE) and the mouse diaphragm model were performed to unravel the various microscopic reaction parameters that contribute to the dynamic equilibrium of AChE inhibition, ageing and reactivation. These data may help to define more precisely the indications and limitations of oxime therapy in organophosphate (OP) poisoning.

2 Diethylphosphoryl-AChE resulting from intoxications with parathion, chlorpyrifos, chlorfenvinphos, diazi non and other OPs is characterized by slow sponta neous reactivation and low propensity for ageing. This kind of phosphorylated enzyme is particularly sus ceptible to reactivation by oximes.

3 None of the oximes tested (pralidoxime, obidoxime, HI 6 and HLö 7) can be regarded as a universally suitable reactivator. Obidoxime turned out to be the most potent and most efficacious oxime in reactivating AChE inhibited by various classes of OP insecticides and tabun. Obidoxime, however, was inferior to HI 6 against soman, sarin, cyclosarin and VX. Pralidoxime was generally less potent.

4 The kinetic data of reactivation established for diethylphosphoryl-AChE of human red cells indicate that the usually recommended dosage to attain a plasma concentration of 4 µg/ml does not permit exploitation of the full therapeutic potential of the oximes, in particular of pralidoxime. However, in suicidal mega-dose poisoning, oximes, even at optimal plasma concentrations, may be unable to cope with the fast re-inhibition of reactivated AChE in the first days following intoxication.

5 It is suggested that oximes be administered by continuous infusion following an initial bolus dose as long as reactivation can be expected and until permanent clinical improvement is achieved.

Key Words: acetylcholinesterase • organophosphates • oximes • ery throcytes • poisoning • therapy

Human & Experimental Toxicology, Vol. 16, No. 8, 466-472 (1997)
DOI: 10.1177/096032719701600808


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
QJMHome page
M. Eddleston, F. Worek, P. Eyer, H. Thiermann, L. Von Meyer, K. Jeganathan, M. H. R. Sheriff, A. H. Dawson, and N. A. Buckley
Poisoning with the S-Alkyl organophosphorus insecticides profenofos and prothiofos
QJM, November 1, 2009; 102(11): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
B. Antonijevic and M. P. Stojiljkovic
Unequal Efficacy of Pyridinium Oximes in Acute Organophosphate Poisoning
Clin. Med. Res., March 1, 2007; 5(1): 71 - 82.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. G. Schier and R. S. Hoffman
Treatment of Sarin Exposure
JAMA, January 14, 2004; 291(2): 182 - 182.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
S. W. Wiener and R. S. Hoffman
Nerve Agents: A Comprehensive Review
J Intensive Care Med, January 1, 2004; 19(1): 22 - 37.
[Abstract] [PDF]


Home page
Toxicol SciHome page
A. Dekundy, R. M. Kaminski, and W. A. Turski
Dizocilpine Improves Beneficial Effects of Cholinergic Antagonists in Anticholinesterase-Treated Mice
Toxicol. Sci., April 1, 2003; 72(2): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. M. White
Chemical and biological weapons. Implications for anaesthesia and intensive care{dagger}
Br. J. Anaesth., August 1, 2002; 89(2): 306 - 324.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Eddleston, L. Szinicz, P. Eyer, and N. Buckley
Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials
QJM, May 1, 2002; 95(5): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
F. Eyer and P. Eyer
Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients
Human and Experimental Toxicology, December 1, 1998; 17(12): 645 - 651.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
H. Thiermann, U. Mast, R. Klimmek, P. Eyer, A. Hibler, R. Pfab, N. Felgenhauer, and T. Zilker
Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients
Human and Experimental Toxicology, August 1, 1997; 16(8): 473 - 480.
[Abstract] [PDF]



Advertisement